Medicines for #cancer and rare diseases, and #ATMPs - mostly cell and gene therapies – are first to be included in the new #HTA framework from January 2025.

More bit.ly/3PwWP2u

#FutureProofingMedicines

What do you think about ATMPs being called the living drugs?

What is the influence of #population size on the #reimbursement amount of #ATMPs in the German #AMNOG ? Get answers and more information in SKC's InnovATion NavigATor for ATMPs. Download for free at eu1.hubs.ly/H08xncw0 #marketaccess #pricing #celltherapy #genetherapy

Dramatic differences in access to Advanced Therapy Medicinal Products (ATMP) across Europe - Neil Grubert
camilla Lund-Cramer

#ATMPs #Belgium #Cancer #PharmaceuticalIndustry #Medicines #Denmark #GeneTherapies #Greece #Netherlands #OncoDaily #Oncology

oncodaily.com/46939.html

Planes, trains and automobiles. Getting to INTERPHEX this year....won't be so easy... but it ain't hard for a NYr either! 🤣

Come talk #CONTAMINATIONCONTROL strategies for ATMPS with me!!

Link to register: interphex.com/en-us/conferen…

John Coleman, Business Unit Director at ATMP logistics provider #YSDSLifeScience , explores the crucial role of logistics providers in ensuring the seamless transport of ATMPs in while adhering to the standards for an optimal vein-to-vein process. nordiclifescience.org/cell-and-gene-…

🎓 Training & retaining #talent is crucial for the creation of an environment that enables #innovation & the discovery of advanced therapies.

At the #AdTherapies2024 conference, we presented the efforts of Catalonia in this regard.

Learn more: tuit.cat/fb8Hu

#ATMPs

The present and future R&D developments in Europe show the science behind advanced therapy medicinal products (ATMPs) is rapidly advancing. What does the path forward look like and what are the lessons learned between industry and academia?
1/4 🧵

Pipeline of the #BioRegion 👇

🔬 73 therapies being developed
🧬 Vide variety of clinical areas (primarily in #oncology , #neurology , #dermatology and minority diseases)
🆕 19 advanced therapies in development

➕ More data in the #BioRegion Report: report.biocat.cat

#ATMPs

2/4
ARM welcomed Massimo Dominici, MD, to #CGMed24 this afternoon for the conference's keynote address.

A key point of his talk was how we can fill the development gaps for ATMPs and get more into the clinic. His key points were:

This week, we're attending Alliance for Regenerative Medicine (ARM)’s Cell & Gene: Meeting on the Med!

If you're attending, catch Jason speaking on the roundtable: Innovative approaches: decentralized manufacturing of ATMPs

Full agenda ➡️ meetingonthemed.com/agenda/